Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025)
Aurora Cannabis (ACB) reported Cash from Investing Activities of -$3.6 million for Q1 2025, down 17.75% year-over-year from -$4.4 million in Q1 2024, and down 56.31% quarter-over-quarter from -$2.3 million in Q4 2024.
Aurora Cannabis (ACB) Cash from Investing Activities (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Cash from Investing Activities data on file, last reported at -$3.6 million in Q1 2025.
- Cash from Investing Activities for Q1 2025 came in at -$3.6 million, down 17.75% year-over-year; the trailing twelve-month figure through Mar 2025 was -$8.6 million (down 188.16% YoY), and the FY2025 annual result was -$10.9 million, down 336.15% from the prior year.
- Cash from Investing Activities retreated to -$3.6 million in Q1 2025 per ACB's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $25.8 million in Q4 2021 and troughed at -$33.3 million in Q3 2021.
- A 5-year average of -$4.2 million and a median of -$2.7 million in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities jumped 770.37% in 2021, then sank 324.38% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at $25.8 million in 2021, then plunged by 58.66% to $10.7 million in 2022, then tumbled by 52.65% to $5.1 million in 2023, then tumbled by 145.45% to -$2.3 million in 2024, then slumped by 56.31% to -$3.6 million in 2025.
- Business Quant data shows ACB's Cash from Investing Activities at -$3.6 million in Q1 2025, -$2.3 million in Q4 2024, and -$2.7 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | -2.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -3.59 Mn |
| Mar 31, 2025 | -3.59 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Sep 30, 2024 | -2.67 Mn |
| Jun 30, 2024 | -11,698.25 |
| Jun 30, 2024 | -11,698.25 |
| Mar 31, 2024 | -3.05 Mn |
| Mar 31, 2024 | -3.05 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | -2.97 Mn |
| Sep 30, 2023 | -2.97 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Sep 30, 2022 | -32.15 Mn |
| Sep 30, 2022 | -32.15 Mn |
| Jun 30, 2022 | -31.17 Mn |
| Jun 30, 2022 | -31.17 Mn |